Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 131

1.

Changing trends in international versus domestic HCV transmission in HIV-positive MSM: A perspective for the DAA scale-up era.

Salazar-Vizcaya L, Kouyos RD, Metzner KJ, Caraballo Cortes K, Böni J, Shah C, Fehr J, Braun DL, Bernasconi E, Mbunkah HA, Hoffmann M, Labhardt N, Cavassini M, Rougemont M, Günthard HF, Keiser O, Rauch A; Swiss HIV Cohort Study.

J Infect Dis. 2019 Feb 13. doi: 10.1093/infdis/jiz069. [Epub ahead of print]

PMID:
30759225
2.

Precision Global Health - The case of Ebola: a scoping review.

Bempong NE, Ruiz De Castañeda R, Schütte S, Bolon I, Keiser O, Escher G, Flahault A.

J Glob Health. 2019 Jun;9(1):010404. doi: 10.7189/jogh.09.010404. Review.

3.

Research priorities to inform "Treat All" policy implementation for people living with HIV in sub-Saharan Africa: a consensus statement from the International epidemiology Databases to Evaluate AIDS (IeDEA).

Yotebieng M, Brazier E, Addison D, Kimmel AD, Cornell M, Keiser O, Parcesepe AM, Onovo A, Lancaster KE, Castelnuovo B, Murnane PM, Cohen CR, Vreeman RC, Davies MA, Duda SN, Yiannoutsos CT, Bono RS, Agler R, Bernard C, Syvertsen JL, Sinayobye JD, Wikramanayake R, Sohn AH, von Groote PM, Wandeler G, Leroy V, Williams CF, Wools-Kaloustian K, Nash D; IeDEA Treat All in sub-Saharan Africa Consensus Statement Working Group.

J Int AIDS Soc. 2019 Jan;22(1):e25218. doi: 10.1002/jia2.25218. Review.

4.

A community outbreak of Legionnaires' disease in Geneva, Switzerland, June to September 2017.

Zanella MC, Yerly S, CherkaouiI A, Renzi G, Mamin A, Lourenço Cordes L, Delaporte E, Baranczuk-Turska Z, Keiser O, Schrenzel J, Harbarth S, Gaia V, Kaiser L.

Swiss Med Wkly. 2018 Dec 2;148:w14687. doi: 10.4414/smw.2018.14687. eCollection 2018 Nov 19.

5.

Mathematical modelling to inform 'treat all' implementation in sub-Saharan Africa: a scoping review.

Kimmel AD, Bono RS, Keiser O, Sinayobye JD, Estill J, Mujwara D, Tymejczyk O, Nash D.

J Virus Erad. 2018 Nov 15;4(Suppl 2):47-54.

6.

Weight gain of HIV-exposed, uninfected children born before and after introduction of the 'Option B+' programme in Malawi.

Msukwa MT, Estill J, Haas AD, van Oosterhout JJ, Tenthani L, Davies MA, Tal K, Phiri N, Spoerri A, Mthiko BC, Chimbwandira F, Keiser O.

AIDS. 2018 Sep 24;32(15):2201-2208. doi: 10.1097/QAD.0000000000001942.

PMID:
30005013
7.

The Effect of Monitoring Viral Load and Tracing Patients Lost to Follow-up on the Course of the HIV Epidemic in Malawi: A Mathematical Model.

Estill J, Kerr CC, Blaser N, Salazar-Vizcaya L, Tenthani L, Wilson DP, Keiser O.

Open Forum Infect Dis. 2018 Apr 27;5(5):ofy092. doi: 10.1093/ofid/ofy092. eCollection 2018 May.

8.

Outcomes of Patients Lost to Follow-up in African Antiretroviral Therapy Programs: Individual Patient Data Meta-analysis.

Chammartin F, Zürcher K, Keiser O, Weigel R, Chu K, Kiragga AN, Ardura-Garcia C, Anderegg N, Laurent C, Cornell M, Tweya H, Haas AD, Rice BD, Geng EH, Fox MP, Hargreaves JR, Egger M.

Clin Infect Dis. 2018 Nov 13;67(11):1643-1652. doi: 10.1093/cid/ciy347.

9.

"I found that I was well and strong": Women's motivations for remaining on ART under Option B+ in Malawi.

Phiri N, Haas AD, Msukwa MT, Tenthani L, Keiser O, Tal K.

PLoS One. 2018 Jun 6;13(6):e0197854. doi: 10.1371/journal.pone.0197854. eCollection 2018.

10.

Microfluidic device for real-time formulation of reagents and their subsequent encapsulation into double emulsions.

Chang JC, Swank Z, Keiser O, Maerkl SJ, Amstad E.

Sci Rep. 2018 May 25;8(1):8143. doi: 10.1038/s41598-018-26542-x.

11.

Cohort profile: The MULTI sTUdy Diabetes rEsearch (MULTITUDE) consortium.

Pino EC, Zuo Y, Maciel De Olivera C, Mahalingaiah S, Keiser O, Moore LL, Li F, Vasan RS, Corkey BE, Kalesan B.

BMJ Open. 2018 May 5;8(5):e020640. doi: 10.1136/bmjopen-2017-020640.

12.

How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countries.

Stuart RM, Grobicki L, Haghparast-Bidgoli H, Panovska-Griffiths J, Skordis J, Keiser O, Estill J, Baranczuk Z, Kelly SL, Reporter I, Kedziora DJ, Shattock AJ, Petravic J, Hussain SA, Grantham KL, Gray RT, Yap XF, Martin-Hughes R, Benedikt CJ, Fraser-Hurt N, Masaki E, Wilson DJ, Gorgens M, Mziray E, Cheikh N, Shubber Z, Kerr CC, Wilson DP.

J Int AIDS Soc. 2018 Apr;21(4):e25097. doi: 10.1002/jia2.25097. Review.

13.

Patterns of caesarean section in HIV infected and non-infected women in Malawi: is caesarean section used for PMTCT?

Tenthani L, van Oosterhout JJ, Haas AD, Msukwa M, Phiri N, Chimbwandira F, Tal K, Aebi-Popp K, Estill J, Keiser O.

BMC Pregnancy Childbirth. 2018 Apr 12;18(1):95. doi: 10.1186/s12884-018-1722-4.

14.

The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDS.

Kelly SL, Martin-Hughes R, Stuart RM, Yap XF, Kedziora DJ, Grantham KL, Hussain SA, Reporter I, Shattock AJ, Grobicki L, Haghparast-Bidgoli H, Skordis-Worrall J, Baranczuk Z, Keiser O, Estill J, Petravic J, Gray RT, Benedikt CJ, Fraser N, Gorgens M, Wilson D, Kerr CC, Wilson DP.

Lancet HIV. 2018 Apr;5(4):e190-e198. doi: 10.1016/S2352-3018(18)30024-9. Epub 2018 Mar 11.

PMID:
29540265
15.

HIV-1 Drug Resistance and Third-Line Therapy Outcomes in Patients Failing Second-Line Therapy in Zimbabwe.

Chimbetete C, Katzenstein D, Shamu T, Spoerri A, Estill J, Egger M, Keiser O.

Open Forum Infect Dis. 2018 Feb 2;5(2):ofy005. doi: 10.1093/ofid/ofy005. eCollection 2018 Feb.

16.

Eliminating hepatitis C virus as a public health threat among HIV-positive men who have sex with men: a multi-modelling approach to understand differences in sexual risk behaviour.

Scott N, Stoové M, Wilson DP, Keiser O, El-Hayek C, Doyle J, Hellard M.

J Int AIDS Soc. 2018 Jan;21(1). doi: 10.1002/jia2.25059.

17.

Trends in hepatitis C-related mortality in Switzerland.

Keiser O, Giudici F, Müllhaupt B, Junker C, Dufour JF, Moradpour D, Bruggmann P, Terziroli B, Semela D, Brezzi M, Bertisch B, Estill J, Negro F, Spoerri A; Swiss Hepatitis C Cohort Study and the Swiss National Cohort.

J Viral Hepat. 2018 Feb;25(2):152-160. doi: 10.1111/jvh.12803. Epub 2017 Nov 20.

PMID:
29159841
18.

Getting it right when budgets are tight: Using optimal expansion pathways to prioritize responses to concentrated and mixed HIV epidemics.

Stuart RM, Kerr CC, Haghparast-Bidgoli H, Estill J, Grobicki L, Baranczuk Z, Prieto L, Montañez V, Reporter I, Gray RT, Skordis-Worrall J, Keiser O, Cheikh N, Boonto K, Osornprasop S, Lavadenz F, Benedikt CJ, Martin-Hughes R, Hussain SA, Kelly SL, Kedziora DJ, Wilson DP.

PLoS One. 2017 Oct 3;12(10):e0185077. doi: 10.1371/journal.pone.0185077. eCollection 2017.

19.

Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis.

Turk T, Bachmann N, Kadelka C, Böni J, Yerly S, Aubert V, Klimkait T, Battegay M, Bernasconi E, Calmy A, Cavassini M, Furrer H, Hoffmann M, Günthard HF, Kouyos RD; Swiss HIV Cohort Study, Aubert V, Battegay M, Bernasconi E, Böni J, Braun DL, Bucher HC, Calmy A, Cavassini M, Ciuffi A, Dollenmaier G, Egger M, Elzi L, Fehr J, Fellay J, Furrer H, Fux CA, Günthard HF, Haerry D, Hasse B, Hirsch HH, Hoffmann M, Hösli I, Kahlert C, Kaiser L, Keiser O, Klimkait T, Kouyos RD, Kovari H, Ledergerber B, Martinetti G, Martinez de Tejada B, Marzolini C, Metzner KJ, Müller N, Nicca D, Pantaleo G, Paioni P, Rauch A, Rudin C, Scherrer AU, Schmid P, Speck R, Stöckle M, Tarr P, Trkola A, Vernazza P, Wandeler G, Weber R, Yerly S.

Elife. 2017 Sep 12;6. pii: e28721. doi: 10.7554/eLife.28721.

20.

HIV transmission and retention in care among HIV-exposed children enrolled in Malawi's prevention of mother-to-child transmission programme.

Haas AD, van Oosterhout JJ, Tenthani L, Jahn A, Zwahlen M, Msukwa MT, Davies MA, Tal K, Phiri N, Spoerri A, Chimbwandira F, Egger M, Keiser O.

J Int AIDS Soc. 2017 Sep 4;20(1):21947. doi: 10.7448/IAS.20.1.21947.

Supplemental Content

Loading ...
Support Center